Latest Breaking News On - Viveve inc - Page 1 : comparemela.com

Viveve Medical, Inc : Viveve Announces Topline Results from Pivotal U S PURSUIT Trial for Treating Female Stress Urinary Incontinence

Study's primary efficacy endpoint was not achieved at 12 months post-treatmentCompany has implemented a reduction in forceCompany will seek strategic alternatives and will be delisted from Nasdaq ENGLEWOOD

Bill berryScott durbinExchange commissionBerry company public relationsSecurities exchangeViveve incViveve medical inc viewViveve medical incViveve medicalPad weight testNasdaq stock marketSecurities exchange actSecurities actInc view

Viveve Medical (VIVE) Reports PURSUIT Trial Did Not Meet Endpoints, Company Shrinks Staff, Intends to Delist

Viveve Medical (VIVE) Reports PURSUIT Trial Did Not Meet Endpoints, Company Shrinks Staff, Intends to Delist
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bill berryScott durbinExchange commissionBerry company public relationsSecurities exchangeViveve incViveve medical incPad weight testViveve systemNasdaq stock marketSecurities exchange actSecurities actViveve medical

Viveve Announces Topline Results from Pivotal U S PURSUIT Trial for Treating Female Stress Urinary Incontinence

Viveve Announces Topline Results from Pivotal U S PURSUIT Trial for Treating Female Stress Urinary Incontinence
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bill berryScott durbinExchange commissionBerry company public relationsSecurities exchangeViveve incViveve medical incWall streetViveve medicalPad weight testNasdaq stock marketSecurities exchange actSecurities act

Viveve Announces Topline Results from Pivotal U S PURSUIT Trial for Treating Female Stress Urinary Incontinence

Viveve Announces Topline Results from Pivotal U S PURSUIT Trial for Treating Female Stress Urinary Incontinence
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Bill berryScott durbinExchange commissionBerry company public relationsSecurities exchangeViveve incViveve medical incViveve medicalPad weight testNasdaq stock marketSecurities exchange actSecurities act

Viveve Medical, Inc : Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded

Topline results of the 12-month primary efficacy endpoint anticipated in January 2023Positive results may support a de novo marketing application for a new U.S. indication for treatment of stress urinary

United statesScott durbinBill berryViveve inc viewInternational consultation on incontinence modular questionnaireDrug administrationViveve incViveve medical incBerry company public relationsSecurities exchangeViveve medicalPad weight testSocial aspectsIncontinence qualityPatient global impressionInternational consultation